Moody's announces completion of a periodic review of ratings of Option Care Health, Inc.
Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Option Care Health, Inc.. Global Credit Research- 05 Mar 2020. New York, March 05, 2020-- Moody's Investors Service has completed a periodic review of the ratings of Option Care Health, Inc. and other ratings that are associated with the same analytical unit.Bioservo Technologies AB is a Sweden-based company within wearable technologies based on bionic soft robotics. It is engaged in developing, producing and selling muscle strengthening equipment based on the patented SEM Technology (Soft Extra Muscle Technology). The technology implies so called intention detection logic that activates the support if the wearer initiates movement with a natural and intuitive movement. This is achieved by sensors that detect the user's action and strengthens this action by activating the motors. Its main product is a SEM Glove. The products are designed for people that have an impaired grip strength caused by injured nerves, weakening in the muscles or pain in the muscles/muscular attachments. The product is applicable in the healthcare and industry sectors.
Moody's Investors Service is a leading provider of credit ratings, research, and risk analysis. Moody's commitment and expertise contributes to transparent and integrated financial markets, protecting the integrity of credit. Our ratings and analysis track debt covering more than:
- 130 countries
11,000 corporate issuers
21,000 public finance issuers
76,000 structured finance obligations
Credit ratings and research help investors analyze the credit risks associated with fixed-income securities. Such independent credit ratings and research also contribute to efficiencies in fixed-income markets and other obligations, such as insurance policies and derivative transactions, by providing credible and independent assessments of credit risk.
Moody’s default studies validate our predictive ratings. Our published research and investor briefings draw thousands of attendees each year and keep investors current with the rationale underlying our credit opinions.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.